205 related articles for article (PubMed ID: 31515079)
21. The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets.
Belayneh R; Weiss K
Adv Exp Med Biol; 2020; 1258():157-166. PubMed ID: 32767240
[TBL] [Abstract][Full Text] [Related]
22. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
23. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.
Moreb JS; Ucar-Bilyeu DA; Khan A
Cancer Chemother Pharmacol; 2017 Feb; 79(2):295-301. PubMed ID: 27942929
[TBL] [Abstract][Full Text] [Related]
24. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1).
Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746
[TBL] [Abstract][Full Text] [Related]
25. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
Huddle BC; Grimley E; Buchman CD; Chtcherbinine M; Debnath B; Mehta P; Yang K; Morgan CA; Li S; Felton J; Sun D; Mehta G; Neamati N; Buckanovich RJ; Hurley TD; Larsen SD
J Med Chem; 2018 Oct; 61(19):8754-8773. PubMed ID: 30221940
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cytosolic class 3 aldehyde dehydrogenase by antisense oligonucleotides in rat hepatoma cells.
Muzio G; Canuto RA; Trombetta A; Maggiora M
Chem Biol Interact; 2001 Jan; 130-132(1-3):219-25. PubMed ID: 11306046
[TBL] [Abstract][Full Text] [Related]
27. A patent review on aldehyde dehydrogenase inhibitors: an overview of small molecule inhibitors from the last decade.
Kundu B; Iyer MR
Expert Opin Ther Pat; 2023 Oct; 33(10):651-668. PubMed ID: 38037334
[TBL] [Abstract][Full Text] [Related]
28. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
Morgan CA; Hurley TD
J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
[TBL] [Abstract][Full Text] [Related]
29. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
Klyosov AA
Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
[TBL] [Abstract][Full Text] [Related]
31. Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.
Rodriguez-Torres M; Allan AL
Clin Exp Metastasis; 2016 Jan; 33(1):97-113. PubMed ID: 26445849
[TBL] [Abstract][Full Text] [Related]
32. Targeting aldehyde dehydrogenase for prostate cancer therapies.
Ma M; He W; Zhao K; Xue L; Xia S; Zhang B
Front Oncol; 2022; 12():1006340. PubMed ID: 36300093
[TBL] [Abstract][Full Text] [Related]
33. ALDH as a Stem Cell Marker in Solid Tumors.
Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
[TBL] [Abstract][Full Text] [Related]
34. ROS activated prodrug for ALDH overexpressed cancer stem cells.
Won M; Kim JH; Ji MS; Kim JS
Chem Commun (Camb); 2021 Dec; 58(1):72-75. PubMed ID: 34874378
[TBL] [Abstract][Full Text] [Related]
35. Identification of 4-(N,N-dipropylamino)benzaldehyde as a potent, reversible inhibitor of mouse and human class I aldehyde dehydrogenase.
Russo J; Chung S; Contreras K; Lian B; Lorenz J; Stevens D; Trousdell W
Biochem Pharmacol; 1995 Jul; 50(3):399-406. PubMed ID: 7646541
[TBL] [Abstract][Full Text] [Related]
36. Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology.
Kato H; Izumi K; Saito T; Ohnuki H; Terada M; Kawano Y; Nozawa-Inoue K; Saito C; Maeda T
Histochem Cell Biol; 2013 Jun; 139(6):847-62. PubMed ID: 23250514
[TBL] [Abstract][Full Text] [Related]
37. The soybean aldehyde dehydrogenase (ALDH) protein superfamily.
Kotchoni SO; Jimenez-Lopez JC; Kayodé AP; Gachomo EW; Baba-Moussa L
Gene; 2012 Mar; 495(2):128-33. PubMed ID: 22226812
[TBL] [Abstract][Full Text] [Related]
38. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Tomita H; Tanaka K; Tanaka T; Hara A
Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
[TBL] [Abstract][Full Text] [Related]
39. Spectroscopic characterisation of interaction of ferulic acid with aldehyde dehydrogenase (ALDH).
Kolawole AO; Agaba RJ; Oluwole MO
Int J Biol Macromol; 2017 May; 98():247-255. PubMed ID: 28104374
[TBL] [Abstract][Full Text] [Related]
40. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
